Literature DB >> 24554818

Adult T Lymphoblastic Leukemia (Pro-T ALL) with Reactive Monocytosis: A Case Report.

Rachna Khera1, Parul Gautam2, Sanjeev Gupta2, Prerna Arora2, Tejinder Singh2, Naresh Gupta2.   

Abstract

Entities:  

Year:  2012        PMID： 24554818      PMCID： PMC3921325          DOI： 10.1007/s12288-012-0179-2

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  22 in total

1.  Antisera to acute lymphoblastic leukemia cells.

Authors:  M F Greaves; G Brown; N T Rapson; T A Lister
Journal:  Clin Immunol Immunopathol       Date:  1975-05

2.  Pro-T ALL: immunophenotypical analyses.

Authors:  M C Béné
Journal:  J Biol Regul Homeost Agents       Date:  2004 Jul-Dec       Impact factor: 1.711

3.  Routine immunophenotyping of acute leukemias.

Authors:  W D Ludwig; E Thiel
Journal:  Blut       Date:  1990-01

4.  Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).

Authors:  R Consolini; A Legitimo; R Rondelli; C Guguelmi; E Barisone; A Lippi; A Cantù-Rajnoldi; M Aricò; V Conter; M G Cocito; M C Putti; A Pession; G Masera; A Biondi; G Basso
Journal:  Haematologica       Date:  1998-11       Impact factor: 9.941

5.  Flow cytometric analysis of de novo acute lymphoblastic leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group.

Authors:  Shotaro Iwamoto; Takao Deguchi; Hideaki Ohta; Nobutaka Kiyokawa; Masahito Tsurusawa; Tomomi Yamada; Kozo Takase; Junichiro Fujimoto; Ryoji Hanada; Hiroki Hori; Keizo Horibe; Yoshihiro Komada
Journal:  Int J Hematol       Date:  2011-07-30       Impact factor: 2.490

6.  CD10 plays a specific role in early thymic development.

Authors:  S Guérin; B Mari; L Maulon; N Belhacène; D Marguet; P Auberger
Journal:  FASEB J       Date:  1997-04       Impact factor: 5.191

7.  Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol.

Authors:  Antonella Vitale; Anna Guarini; Cristina Ariola; Marco Mancini; Cristina Mecucci; Antonio Cuneo; Fabrizio Pane; Giuseppe Saglio; Giuseppe Cimino; Agostino Tafuri; Giovanna Meloni; Francesco Fabbiano; Anna Recchia; Maria Grazia Kropp; Mauro Krampera; Nicola Cascavilla; Felicetto Ferrara; Antonio Romano; Patrizio Mazza; Claudio Fozza; Francesca Paoloni; Marco Vignetti; Robin Foà
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

8.  Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364.

Authors:  M S Czuczman; R K Dodge; C C Stewart; S R Frankel; F R Davey; B L Powell; T P Szatrowski; C A Schiffer; R A Larson; C D Bloomfield
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

9.  [Acute lymphoblastic leukemia with T + PH1 monocytosis: a case report].

Authors:  Nejia Braham Jmili; Halima Sendi; Abderrahim Khelif
Journal:  Ann Biol Clin (Paris)       Date:  2011 Jul-Aug       Impact factor: 0.459

10.  Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study group.

Authors:  J Donadieu; M F Auclerc; A Baruchel; T Leblanc; J Landman-Parker; Y Perel; G Michel; G Cornu; P Bordigoni; D Sommelet; G Leverger; C Hill; G Schaison
Journal:  Br J Haematol       Date:  1998-08       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.